Icon (ICLR) Announces Earnings Results

Business



[ad_1]

Icon logo "title =" Icon logo "clbad =" companylogo "/> Icon (NASDAQ: ICLR) issued its earnings results on Wednesday.The medical research company reported $ 1.31 per share for the quarter, missing badysts ($ 0.17), Fidelity Earnings reports. The business had revenue of $ 641.60 million for the quarter, compared to the consensus estimate of $ 618.64 million. During the same period in the previous year, the firm earned $ 1.34 EPS The company was up 48.9% compared to the same quarter last year. </p> <p> Shares of stock icon traded up $ 4.92 during trading on Thursday, hitting $ 144.86. The stock has a market volume of 387,800 shares, compared to its average volume of 269,328, The stock has a market cap of $ 7.55 billion, a P / E ratio of 26.21, a PEG ratio of 2.18 and a beta of 0.45. month low of $ 99.77 and a 12 month high of $ 146.31. a debt-to-equity ratio of 0.29, a quick ratio of 1.85 and a current ratio of 1.85. </p> <p> A number of equities research badysts reported on ICLR shares. BidaskClub Raised Shares of Icon from a "hold" rating to a "buy" rating in a report on Wednesday, March 28th. Zacks Investment Research shares of a rating on a "report" on a report on Thursday, April 19th. Jefferies Financial Group is a $ 1 billion buyout share price. KeyCorp upped their price target on shares of Icon from $ 130.00 to $ 152.00 and gave the stock an "overweight" rating in a report on Monday, June 18th. Finally, SunTrust Banks is worth $ 1.50 a share of the value of a dollar. Two badysts have rated the stock with a hold rating, and have had a strong buy rating. The stock currently has a consensus rating of "Buy" and a consensus price target of $ 135.70. </p> <p><strong> Icon Company Profile </strong> </p> <p> ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology , and medical device industries in Ireland, United States, and internationally. It is a specialization in the strategic development, management, and badysis of various clinical trial phases of clinical trials. </p> <p> Featured Story: Understanding Price to Earnings Ratio (PE) <!--ViewCount:type=e&id=362886--></p> <p style= Earnings History for Icon (Nasdaq: ICLR) "title =" Earnings History for Icon (NASDAQ: ICLR) "</p> <p> <!-- end inline unit --></p> <p> <!-- end main text --></p> <p> <!-- Invalidate Article --></p> <p> <!-- End Invalidate --></p> <p><!--Begin Footer Opt-In--></p> <p style= Receive News & Comments for Daily Icon – concise daily summary MarketBeat.com's FREE daily email newsletter.

[ad_2]
Source link

Tags

Powered by https://naaju.com/ireland | Designed by Naaju
© Copyright 2024, All Rights Reserved